Trend analysis of the dosimetric impact of anatomical changes during proton therapy for maxillary sinus carcinoma. Issue 9 (17th August 2021)

• Record Type: Journal Article
• Authors: Narita, Yuki; Kato, Takahiro; Ono, Takashi; Oyama, Sho; Yamazaki, Yuhei; Ouchi, Hisao; Takemasa, Kimihiro; Murakami, Masao
• Is Part Of: Journal of applied clinical medical physics. Volume 22:Issue 9(2021)
• Page Start: 298
• Page End: 306
• Publication Date: 2021-08-17
• Subjects: adaptive radiotherapy -- anatomical change -- maxillary sinus carcinoma -- proton therapy; Medical physics -- Periodicals; Clinical medicine -- Periodicals; Health Physics; Clinical Medicine; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; 610.153
• DOI: 10.1002/acm2.13391
• Languages: English
• ISSNs: 1526-9914

Abstract

Abstract: Purpose: Anatomical changes, such as shrinkage and aeration, can affect dose distribution in proton therapy (PT) for maxillary sinus carcinoma (MSC). These changes can affect the dose to the target and organs at risk (OARs); however, when these changes occur during PT is unclear. This study aimed to investigate the dosimetric impact of anatomical changes during PT. Materials and Methods: Fifteen patients with MSC were enrolled in this study. Initial PT plans were generated based on initial computed tomography (CT) images. Several repeat CT images were obtained to confirm anatomical changes during PT. Evaluation PT plans were generated by copying initial PT plans to repeat CT images. The dose differences of the target and OARs were evaluated by comparing both the plans. Results: At 3–4 weeks after the initiation of PT, the target volume reduced by approximately 10% as compared with the initial volume. Consequently, the target volumes gradually varied until the end of treatment. The value of V95 (volume that received 95% of the prescription dose) in the clinical target volume of the evaluation PT plan was similar to that of the initial PT plan. However, the dose to OARs, such as the contralateral optic nerve, contralateral eyeball, brainstem, and optic chiasm, increased significantly from the middle to the later phases of the treatment course. In contrast, there was a slight dose difference in the ipsilateral optic apparatus. Conclusion: The trend analysis in this study showed that anatomical changes appeared 3–4 weeks after the start of PT, and the dose to the OARs tended to increase. Therefore, it is recommended to check the status of tumor 3–4 weeks after the start of treatment to avoid the deterioration of dose distribution due to these changes.